Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trialMichel Seymour, Philip Quirke, Jonathan Wadsley et al.|The Lancet Oncology|2013Cited by 392
A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)Gary Middleton, Michel Seymour, Sarah Brown et al.|European Journal of Cancer|2013Cited by 24
6007 ORAL Panitumumab in Combination With Irinotecan for Chemoresistant Advanced Colorectal Cancer: Results of PICCOLO, a Large Randomised Trial With Prospective Molecular StratificationMichel Seymour, Philip Quirke, Sarah Brown et al.|European Journal of Cancer|2011Cited by 7
REsolution of Symptoms afTer Oesophago-gastric cancer REsection delphi (RESTOREd)—standardizing the definition, investigation and management of gastrointestinal symptoms and conditions after surgeryBen Byrne, Michelle Fanning, K Siaw-Acheampong et al.|British journal of surgery|2024Cited by 5